메뉴 건너뛰기




Volumn 66, Issue 7, 2012, Pages 622-630

New directions in cardiovascular risk assessment: The role of secondary risk stratification markers

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; GLICLAZIDE; INDAPAMIDE PLUS PERINDOPRIL; LIPOPROTEIN A; N(G),N(G) DIMETHYLARGININE; TROPONIN;

EID: 84862746463     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02956.x     Document Type: Review
Times cited : (25)

References (105)
  • 1
    • 78650023399 scopus 로고    scopus 로고
    • ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Greenland P, Alpert JS, Beller GA, et al., ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010; 56: 2182-99.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 2182-2199
    • Greenland, P.1    Alpert, J.S.2    Beller, G.A.3
  • 3
    • 33644810298 scopus 로고    scopus 로고
    • JBS 2: The Joint British Societies' guidelines for prevention of cardiovascular disease in clinical practice
    • British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association.
    • British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: the Joint British Societies' guidelines for prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl. V): v1-v52.
    • (2005) Heart , vol.91 , Issue.SUPPL. V
  • 4
    • 64149124397 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence. London, UK: National Institute for Health and Clinical Excellence, (Jun 17. Report No.: CG67).
    • National Institute for Health and Clinical Excellence. Lipid Modification. London, UK: National Institute for Health and Clinical Excellence, 2008 (Jun 17. Report No.: CG67).
    • (2008) Lipid Modification
  • 5
    • 1942488952 scopus 로고    scopus 로고
    • Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease
    • DOI 10.1016/j.ehj.2003.11.012
    • Emberson J, Whincup P, Morris R, Walker M, Ebrahim S,. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004; 25: 484-91. (Pubitemid 38524273)
    • (2004) European Heart Journal , vol.25 , Issue.6 , pp. 484-491
    • Emberson, J.1    Whincup, P.2    Morris, R.3    Walker, M.4    Ebrahim, S.5
  • 6
    • 33847042709 scopus 로고    scopus 로고
    • Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: A cohort study
    • Penning-van Beest FJ, Termorshuizen F, Goettsch WG, Klungel OH, Kastelein JJ, Herings RM,. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 2007; 28: 154-9.
    • (2007) Eur Heart J , vol.28 , pp. 154-159
    • Penning-Van Beest, F.J.1    Termorshuizen, F.2    Goettsch, W.G.3    Klungel, O.H.4    Kastelein, J.J.5    Herings, R.M.6
  • 8
    • 0346171341 scopus 로고    scopus 로고
    • Framingham-based Tools to Calculate the Global Risk of Coronary Heart Disease: A Systematic Review of Tools for Clinicians
    • DOI 10.1111/j.1525-1497.2003.30107.x
    • Sheridan S, Pignone M, Mulrow C,. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med 2003; 18: 1039-52. (Pubitemid 38091400)
    • (2003) Journal of General Internal Medicine , vol.18 , Issue.12 , pp. 1039-1052
    • Sheridan, S.1    Pignone, M.2    Mulrow, C.3
  • 9
    • 79951977933 scopus 로고    scopus 로고
    • Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: How to choose
    • Tunstall-Pedoe H,. Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose. Heart 2011; 97: 442-4.
    • (2011) Heart , vol.97 , pp. 442-444
    • Tunstall-Pedoe, H.1
  • 10
    • 36348937783 scopus 로고    scopus 로고
    • Assessing risk of myocardial infarction and stroke: New data from the Prospective Cardiovascular Münster (PROCAM) study
    • DOI 10.1111/j.1365-2362.2007.01888.x
    • Assmann G, Schulte H, Cullen P, Seedorf U,. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study. Eur J Clin Invest 2007; 37: 925-32. (Pubitemid 350151189)
    • (2007) European Journal of Clinical Investigation , vol.37 , Issue.12 , pp. 925-932
    • Assmann, G.1    Schulte, H.2    Cullen, P.3    Seedorf, U.4
  • 12
    • 68249129902 scopus 로고    scopus 로고
    • An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
    • Collins GS, Altman DG,. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009; 339: b2584.
    • (2009) BMJ , vol.339
    • Collins, G.S.1    Altman, D.G.2
  • 13
    • 68249112857 scopus 로고    scopus 로고
    • QRISK or Framingham for predicting cardiovascular risk?
    • Jackson R, Marshall R, Kerr A, Riddell T, Wells S,. QRISK or Framingham for predicting cardiovascular risk? BMJ 2009; 339: b2673.
    • (2009) BMJ , vol.339
    • Jackson, R.1    Marshall, R.2    Kerr, A.3    Riddell, T.4    Wells, S.5
  • 14
    • 79955778070 scopus 로고    scopus 로고
    • Screening for future cardiovascular disease using age alone compared with multiple risk factors and age
    • Wald NJ, Simmonds M, Morris JK,. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS ONE 2011; 6: e18742.
    • (2011) PLoS ONE , vol.6
    • Wald, N.J.1    Simmonds, M.2    Morris, J.K.3
  • 15
    • 0141917518 scopus 로고    scopus 로고
    • Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: Impact of regression dilution bias
    • DOI 10.1016/S0195-668X(03)00471-8
    • Emberson JR, Whincup PH, Morris RW, Walker M,. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J 2003; 24: 1719-26. (Pubitemid 37236860)
    • (2003) European Heart Journal , vol.24 , Issue.19 , pp. 1719-1726
    • Emberson, J.R.1    Whincup, P.H.2    Morris, R.W.3    Walker, M.4
  • 16
    • 0036702143 scopus 로고    scopus 로고
    • Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes
    • DOI 10.1097/00043798-200208000-00002
    • Reynolds TM, Twomey P, Wierzbicki AS,. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. J Cardiovasc Risk 2002; 9: 183-90. (Pubitemid 35265941)
    • (2002) Journal of Cardiovascular Risk , vol.9 , Issue.4 , pp. 183-190
    • Reynolds, T.M.1    Twomey, P.2    Wierzbicki, A.S.3
  • 17
    • 78651392469 scopus 로고    scopus 로고
    • Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: Cohort study using QResearch database
    • Hippisley-Cox J, Coupland C, Robson J, Brindle P,. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 2010; 341: c6624.
    • (2010) BMJ , vol.341
    • Hippisley-Cox, J.1    Coupland, C.2    Robson, J.3    Brindle, P.4
  • 18
    • 33644868473 scopus 로고    scopus 로고
    • Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
    • Lloyd-Jones DM, Leip EP, Larson MG, et al., Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-8.
    • (2006) Circulation , vol.113 , pp. 791-798
    • Lloyd-Jones, D.M.1    Leip, E.P.2    Larson, M.G.3
  • 19
    • 33846797790 scopus 로고    scopus 로고
    • Risk Factor Burden in Middle Age and Lifetime Risks for Cardiovascular and Non-Cardiovascular Death (Chicago Heart Association Detection Project in Industry)
    • DOI 10.1016/j.amjcard.2006.09.099, PII S0002914906021606
    • Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P,. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol 2007; 99: 535-40. (Pubitemid 46215561)
    • (2007) American Journal of Cardiology , vol.99 , Issue.4 , pp. 535-540
    • Lloyd-Jones, D.M.1    Dyer, A.R.2    Wang, R.3    Daviglus, M.L.4    Greenland, P.5
  • 20
    • 60549087325 scopus 로고    scopus 로고
    • Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: The coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis
    • Berry JD, Liu K, Folsom AR, et al., Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009; 119: 382-9.
    • (2009) Circulation , vol.119 , pp. 382-389
    • Berry, J.D.1    Liu, K.2    Folsom, A.R.3
  • 21
    • 84655169207 scopus 로고    scopus 로고
    • Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: A systematic review
    • Peters SA, den Ruijter HM, Bots ML, Moons KG,. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012; 98: 177-84.
    • (2012) Heart , vol.98 , pp. 177-184
    • Peters, S.A.1    Den Ruijter, H.M.2    Bots, M.L.3    Moons, K.G.4
  • 22
    • 44849117820 scopus 로고    scopus 로고
    • Surrogate markers, atherosclerosis and cardiovascular disease prevention
    • DOI 10.1111/j.1742-1241.2008.01794.x
    • Wierzbicki AS,. Surrogate markers, atherosclerosis and cardiovascular disease prevention. Int J Clin Pract 2008; 62: 981-7. (Pubitemid 351793602)
    • (2008) International Journal of Clinical Practice , vol.62 , Issue.7 , pp. 981-987
    • Wierzbicki, A.S.1
  • 23
    • 57749210419 scopus 로고    scopus 로고
    • C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men
    • 4p.
    • Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR,. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008; 118: 2243-51. 4p.
    • (2008) Circulation , vol.118 , pp. 2243-2251
    • Ridker, P.M.1    Paynter, N.P.2    Rifai, N.3    Gaziano, J.M.4    Cook, N.R.5
  • 24
    • 70349972800 scopus 로고    scopus 로고
    • Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force
    • Helfand M, Buckley DI, Freeman M, et al., Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 496-507.
    • (2009) Ann Intern Med , vol.151 , pp. 496-507
    • Helfand, M.1    Buckley, D.I.2    Freeman, M.3
  • 25
    • 70349742564 scopus 로고    scopus 로고
    • C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. Preventive Services Task Force
    • Buckley DI, Fu R, Freeman M, Rogers K, Helfand M,. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 483-95.
    • (2009) Ann Intern Med , vol.151 , pp. 483-495
    • Buckley, D.I.1    Fu, R.2    Freeman, M.3    Rogers, K.4    Helfand, M.5
  • 26
    • 70349177508 scopus 로고    scopus 로고
    • Value and limitations of existing scores for the assessment of cardiovascular risk: A review for clinicians
    • Cooney MT, Dudina AL, Graham IM,. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009; 54: 1209-27.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1209-1227
    • Cooney, M.T.1    Dudina, A.L.2    Graham, I.M.3
  • 27
    • 84860113852 scopus 로고    scopus 로고
    • Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
    • Moons KG, Kengne AP, Woodward M, et al,. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012; 98: 683-90.
    • (2012) Heart , vol.98 , pp. 683-690
    • Moons, K.G.1    Kengne, A.P.2    Woodward, M.3
  • 28
    • 84860159431 scopus 로고    scopus 로고
    • Risk prediction models: II. External validation, model updating, and impact assessment
    • Moons KG, Kengne AP, Grobbee DE, et al,. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012; 98: 691-8.
    • (2012) Heart , vol.98 , pp. 691-698
    • Moons, K.G.1    Kengne, A.P.2    Grobbee, D.E.3
  • 29
    • 78649286115 scopus 로고    scopus 로고
    • Methods for evaluating novel biomarkers - A new paradigm
    • Cook NR,. Methods for evaluating novel biomarkers-a new paradigm. Int J Clin Pract 2010; 64: 1723-7.
    • (2010) Int J Clin Pract , vol.64 , pp. 1723-1727
    • Cook, N.R.1
  • 30
    • 77149133745 scopus 로고    scopus 로고
    • Improvement of cardiovascular risk prediction: Time to review current knowledge, debates, and fundamentals on how to assess test characteristics
    • Romanens M, Ackermann F, Spence JD, et al., Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics. Eur J Cardiovasc Prev Rehabil 2010; 17: 18-23.
    • (2010) Eur J Cardiovasc Prev Rehabil , vol.17 , pp. 18-23
    • Romanens, M.1    Ackermann, F.2    Spence, J.D.3
  • 31
    • 81855194377 scopus 로고    scopus 로고
    • Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?
    • de Graaf J, Holewijn S, Stalenhoef AF, Sniderman AD,. Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification? Curr Opin Lipidol 2011; 22: 454-9.
    • (2011) Curr Opin Lipidol , vol.22 , pp. 454-459
    • De Graaf, J.1    Holewijn, S.2    Stalenhoef, A.F.3    Sniderman, A.D.4
  • 32
    • 79952228087 scopus 로고    scopus 로고
    • Performance of reclassification statistics in comparing risk prediction models
    • Cook NR, Paynter NP,. Performance of reclassification statistics in comparing risk prediction models. Biom J 2011; 53: 237-58.
    • (2011) Biom J , vol.53 , pp. 237-258
    • Cook, N.R.1    Paynter, N.P.2
  • 33
    • 73849094087 scopus 로고    scopus 로고
    • Assessing the performance of prediction models: A framework for traditional and novel measures
    • Steyerberg EW, Vickers AJ, Cook NR, et al., Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21: 128-38.
    • (2010) Epidemiology , vol.21 , pp. 128-138
    • Steyerberg, E.W.1    Vickers, A.J.2    Cook, N.R.3
  • 34
    • 84861328429 scopus 로고    scopus 로고
    • A review of family history of cardiovascular disease: Risk factor and research tool
    • Bannerjee A,. A review of family history of cardiovascular disease: risk factor and research tool. Int J Clin Pract 2012; 66: 536-43.
    • (2012) Int J Clin Pract , vol.66 , pp. 536-543
    • Bannerjee, A.1
  • 37
    • 33846630433 scopus 로고    scopus 로고
    • Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
    • DOI 10.1136/hrt.2006.108167
    • Woodward M, Brindle P, Tunstall-Pedoe H,. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172-6. (Pubitemid 46180289)
    • (2007) Heart , vol.93 , Issue.2 , pp. 172-176
    • Woodward, M.1    Brindle, P.2    Tunsfall-Pedoe, H.3
  • 39
    • 51249096285 scopus 로고    scopus 로고
    • Familial hypercholesterolaemia: Summary of NICE guidance
    • Wierzbicki AS, Humphries SE, Minhas R,. Familial hypercholesterolaemia: summary of NICE guidance. BMJ 2008; 337: a1095.
    • (2008) BMJ , vol.337
    • Wierzbicki, A.S.1    Humphries, S.E.2    Minhas, R.3
  • 41
    • 0026762806 scopus 로고
    • Familial lipoprotein disorders in patients with premature coronary artery disease
    • Genest JJ Jr, Martin-Munley SS, McNamara JR, et al., Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2025-33.
    • (1992) Circulation , vol.85 , pp. 2025-2033
    • Genest, Jr.J.J.1    Martin-Munley, S.S.2    McNamara, J.R.3
  • 42
    • 78651323379 scopus 로고    scopus 로고
    • Genetics of myocardial infarction: A progress report
    • Schunkert H, Erdmann J, Samani NJ,. Genetics of myocardial infarction: a progress report. Eur Heart J 2010; 31: 918-25.
    • (2010) Eur Heart J , vol.31 , pp. 918-925
    • Schunkert, H.1    Erdmann, J.2    Samani, N.J.3
  • 43
    • 0034945516 scopus 로고    scopus 로고
    • Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation
    • D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P,. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-7. (Pubitemid 32640849)
    • (2001) Journal of the American Medical Association , vol.286 , Issue.2 , pp. 180-187
    • D'Agostino Sr., R.B.1    Grundy, S.2    Sullivan, L.M.3    Wilson, P.4
  • 44
    • 33748567372 scopus 로고    scopus 로고
    • Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review
    • DOI 10.1136/hrt.2006.087932
    • Brindle P, Beswick A, Fahey T, Ebrahim S,. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006; 92: 1752-9. (Pubitemid 44851316)
    • (2006) Heart , vol.92 , Issue.12 , pp. 1752-1759
    • Brindle, P.1    Beswick, A.2    Fahey, T.3    Ebrahim, S.4
  • 45
    • 70549113081 scopus 로고    scopus 로고
    • Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study)
    • Sacco RL, Khatri M, Rundek T, et al., Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol 2009; 54: 2303-11.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 2303-2311
    • Sacco, R.L.1    Khatri, M.2    Rundek, T.3
  • 46
    • 69549092208 scopus 로고    scopus 로고
    • Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US
    • Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G,. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 2009; 55: 1627-36.
    • (2009) Clin Chem , vol.55 , pp. 1627-1636
    • Cushman, M.1    McClure, L.A.2    Howard, V.J.3    Jenny, N.S.4    Lakoski, S.G.5    Howard, G.6
  • 47
    • 33750297384 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease: A web-based risk score for seven British black and minority ethnic groups
    • DOI 10.1136/hrt.2006.092346
    • Brindle P, May M, Gill P, et al., Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart 2006; 92: 1595-602. (Pubitemid 44629163)
    • (2006) Heart , vol.92 , Issue.11 , pp. 1595-1602
    • Brindle, P.1    May, M.2    Gill, P.3    Cappuccio, F.4    D'Agostino Sr., R.5    Fischbacher, C.6    Ebrahim, S.7
  • 48
    • 77951265835 scopus 로고    scopus 로고
    • Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study
    • Brunner EJ, Shipley MJ, Marmot MG, Kivimaki M, Witte DR,. Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study. Diabet Med 2010; 27: 550-5.
    • (2010) Diabet Med , vol.27 , pp. 550-555
    • Brunner, E.J.1    Shipley, M.J.2    Marmot, M.G.3    Kivimaki, M.4    Witte, D.R.5
  • 49
    • 65349174438 scopus 로고    scopus 로고
    • Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the
    • Simmons RK, Coleman RL, Price HC, et al., Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the. Diabetes Care 2009; 32: 708-13.
    • (2009) Diabetes Care , vol.32 , pp. 708-713
    • Simmons, R.K.1    Coleman, R.L.2    Price, H.C.3
  • 51
    • 38049177286 scopus 로고    scopus 로고
    • Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study
    • Kamstrup PR, Benn M, Tybaerg-Hansen A, Nordestgaard BG,. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008; 117: 176-84.
    • (2008) Circulation , vol.117 , pp. 176-184
    • Kamstrup, P.R.1    Benn, M.2    Tybaerg-Hansen, A.3    Nordestgaard, B.G.4
  • 52
    • 78649888517 scopus 로고    scopus 로고
    • Lipoprotein(a) as a cardiovascular risk factor: Current status
    • Nordestgaard BG, Chapman MJ, Ray K, et al., Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31: 2844-53.
    • (2010) Eur Heart J , vol.31 , pp. 2844-2853
    • Nordestgaard, B.G.1    Chapman, M.J.2    Ray, K.3
  • 55
    • 73449130797 scopus 로고    scopus 로고
    • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis
    • Kaptoge S, Di AE, Lowe G, et al., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-40.
    • (2010) Lancet , vol.375 , pp. 132-140
    • Kaptoge, S.1    Di, A.E.2    Lowe, G.3
  • 56
    • 59649106810 scopus 로고    scopus 로고
    • National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: Emerging biomarkers for primary prevention of cardiovascular disease
    • Myers GL, Christenson RH, Cushman M, et al., National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009; 55: 378-84.
    • (2009) Clin Chem , vol.55 , pp. 378-384
    • Myers, G.L.1    Christenson, R.H.2    Cushman, M.3
  • 57
    • 2142695734 scopus 로고    scopus 로고
    • Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
    • DOI 10.1161/01.CIR.0000125690.80303.A8
    • Ridker PM, Cook N,. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109: 1955-9. (Pubitemid 38544485)
    • (2004) Circulation , vol.109 , Issue.16 , pp. 1955-1959
    • Ridker, P.M.1    Cook, N.2
  • 58
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • Ridker PM, Danielson E, Fonseca FA, et al., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207.
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 59
    • 63649095045 scopus 로고    scopus 로고
    • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial
    • Ridker PM, Danielson E, Fonseca FA, et al., Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009; 373: 1175-82.
    • (2009) Lancet , vol.373 , pp. 1175-1182
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 60
    • 84863116686 scopus 로고    scopus 로고
    • Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: Observations from the Anglo-Scandinavian Cardiac Outcomes Trial
    • Sever PS, Poulter NR, Chang CL, et al., Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J 2012; 33: 486-94.
    • (2012) Eur Heart J , vol.33 , pp. 486-494
    • Sever, P.S.1    Poulter, N.R.2    Chang, C.L.3
  • 61
    • 79958219634 scopus 로고    scopus 로고
    • Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study
    • Herder C, Baumert J, Zierer A, et al., Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS ONE 2011; 6: e19852.
    • (2011) PLoS ONE , vol.6
    • Herder, C.1    Baumert, J.2    Zierer, A.3
  • 64
    • 79959499350 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease
    • Wannamethee SG, Welsh P, Lowe GD, et al., N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011; 58: 56-64.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 56-64
    • Wannamethee, S.G.1    Welsh, P.2    Lowe, G.D.3
  • 65
    • 51749093324 scopus 로고    scopus 로고
    • Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    • Davidson MH, Corson MA, Alberts MJ, et al., Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol 2008; 101: 51F-7F.
    • (2008) Am J Cardiol , vol.101
    • Davidson, M.H.1    Corson, M.A.2    Alberts, M.J.3
  • 66
    • 77951605907 scopus 로고    scopus 로고
    • Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies
    • Lp-PLA(2) Studies Collaboration
    • Lp-PLA(2) Studies Collaboration, Thompson A, Gao P, et al., Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 2010; 375: 1536-44.
    • (2010) Lancet , vol.375 , pp. 1536-1544
    • Thompson, A.1    Gao, P.2
  • 67
    • 4944261232 scopus 로고    scopus 로고
    • 2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from Southern Germany
    • DOI 10.1161/01.CIR.0000143377.53389.C8
    • Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C,. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004; 110: 1903-8. (Pubitemid 39331899)
    • (2004) Circulation , vol.110 , Issue.14 , pp. 1903-1908
    • Koenig, W.1    Khuseyinova, N.2    Lowel, H.3    Trischler, G.4    Meisinger, C.5
  • 68
    • 77956306449 scopus 로고    scopus 로고
    • Lipoprotein-associated phospholipase A activity and mass in relation to vascular disease and nonvascular mortality
    • Heart Protection Study Group.
    • Heart Protection Study Group. Lipoprotein-associated phospholipase A activity and mass in relation to vascular disease and nonvascular mortality. J Intern Med 2010; 268: 348-58.
    • (2010) J Intern Med , vol.268 , pp. 348-358
  • 69
    • 33747079319 scopus 로고    scopus 로고
    • Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
    • DOI 10.1161/CIRCULATIONAHA.105.590927, PII 0000301720060718000007
    • Blankenberg S, McQueen MJ, Smieja M, et al., Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006; 114: 201-8. (Pubitemid 44297113)
    • (2006) Circulation , vol.114 , Issue.3 , pp. 201-208
    • Blankenberg, S.1    McQueen, M.J.2    Smieja, M.3    Pogue, J.4    Balion, C.5    Lonn, E.6    Rupprecht, H.J.7    Bickel, C.8    Tiret, L.9    Cambien, F.10    Gerstein, H.11    Munzel, T.12    Yusuf, S.13
  • 70
    • 33846192416 scopus 로고    scopus 로고
    • N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study
    • Emberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R,. N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol 2007; 49: 311-9.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 311-319
    • Emberson, J.R.1    Ng, L.L.2    Armitage, J.3    Bowman, L.4    Parish, S.5    Collins, R.6
  • 71
    • 74949119309 scopus 로고    scopus 로고
    • Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community
    • Schnabel RB, Larson MG, Yamamoto JF, et al., Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121: 200-7.
    • (2010) Circulation , vol.121 , pp. 200-207
    • Schnabel, R.B.1    Larson, M.G.2    Yamamoto, J.F.3
  • 72
    • 60649118584 scopus 로고    scopus 로고
    • Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study
    • Schnabel RB, Sullivan LM, Levy D, et al., Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739-45.
    • (2009) Lancet , vol.373 , pp. 739-745
    • Schnabel, R.B.1    Sullivan, L.M.2    Levy, D.3
  • 73
    • 77953356167 scopus 로고    scopus 로고
    • Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project
    • Blankenberg S, Zeller T, Saarela O, et al., Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010; 121: 2388-97.
    • (2010) Circulation , vol.121 , pp. 2388-2397
    • Blankenberg, S.1    Zeller, T.2    Saarela, O.3
  • 74
    • 84871705284 scopus 로고    scopus 로고
    • A multiple biomarker risk score for guiding clinical decisions using a decision curve approach
    • in press.
    • Hughes MF, Saarela O, Blankenberg S, et al., A multiple biomarker risk score for guiding clinical decisions using a decision curve approach. Eur J Cardiovasc Prev Rehabil 2012; in press.
    • (2012) Eur J Cardiovasc Prev Rehabil
    • Hughes, M.F.1    Saarela, O.2    Blankenberg, S.3
  • 75
    • 84856077397 scopus 로고    scopus 로고
    • Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: Results from the AtheroGene study
    • Wild PS, Schnabel RB, Lubos E, et al., Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. Clin Chem 2012; 58: 226-36.
    • (2012) Clin Chem , vol.58 , pp. 226-236
    • Wild, P.S.1    Schnabel, R.B.2    Lubos, E.3
  • 76
    • 67649992452 scopus 로고    scopus 로고
    • Novel and conventional biomarkers for prediction of incident cardiovascular events in the community
    • Melander O, Newton-Cheh C, Almgren P, et al., Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49-57.
    • (2009) JAMA , vol.302 , pp. 49-57
    • Melander, O.1    Newton-Cheh, C.2    Almgren, P.3
  • 77
    • 79955881524 scopus 로고    scopus 로고
    • The 10 commandments of troponin, with special reference to high sensitivity assays
    • Jaffe AS,. The 10 commandments of troponin, with special reference to high sensitivity assays. Heart 2011; 97: 940-6.
    • (2011) Heart , vol.97 , pp. 940-946
    • Jaffe, A.S.1
  • 78
    • 79954631118 scopus 로고    scopus 로고
    • Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study
    • Saunders JT, Nambi V, de Lemos JA, et al., Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011; 123: 1367-76.
    • (2011) Circulation , vol.123 , pp. 1367-1376
    • Saunders, J.T.1    Nambi, V.2    De Lemos, J.A.3
  • 79
    • 79959502297 scopus 로고    scopus 로고
    • Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: The Women's Health Study
    • Everett BM, Cook NR, Magnone MC, et al., Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011; 123: 2811-8.
    • (2011) Circulation , vol.123 , pp. 2811-2818
    • Everett, B.M.1    Cook, N.R.2    Magnone, M.C.3
  • 80
    • 84860685483 scopus 로고    scopus 로고
    • Increased Cardiac Troponin i as Measured by a High-Sensitivity Assay Is associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey
    • Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV,. Increased Cardiac Troponin I as Measured by a High-Sensitivity Assay Is associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey. Clin Chem 2012; 58: 930-5.
    • (2012) Clin Chem , vol.58 , pp. 930-935
    • Apple, F.S.1    Steffen, L.M.2    Pearce, L.A.3    Murakami, M.M.4    Luepker, R.V.5
  • 81
    • 84861690510 scopus 로고    scopus 로고
    • Troponin-Specific Autoantibody Interference in Different Cardiac Troponin i Assay Configurations
    • in press.
    • Savukoski T, Engstrom E, Engblom J, et al., Troponin-Specific Autoantibody Interference in Different Cardiac Troponin I Assay Configurations. Clin Chem 2012; in press.
    • (2012) Clin Chem
    • Savukoski, T.1    Engstrom, E.2    Engblom, J.3
  • 82
    • 33645501775 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
    • Boger RH,. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006; 38: 126-36.
    • (2006) Ann Med , vol.38 , pp. 126-136
    • Boger, R.H.1
  • 84
    • 78049257283 scopus 로고    scopus 로고
    • Cardiovascular risk scores in the prediction of subclinical atherosclerosis in young adults: Evidence from the cardiovascular risk in a young Finns study
    • Raiko JR, Magnussen CG, Kivimaki M, et al., Cardiovascular risk scores in the prediction of subclinical atherosclerosis in young adults: evidence from the cardiovascular risk in a young Finns study. Eur J Cardiovasc Prev Rehabil 2010; 17: 549-55.
    • (2010) Eur J Cardiovasc Prev Rehabil , vol.17 , pp. 549-555
    • Raiko, J.R.1    Magnussen, C.G.2    Kivimaki, M.3
  • 85
    • 84860141191 scopus 로고    scopus 로고
    • The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: A systematic review
    • Peters SA, den Ruijter HM, Bots ML,. The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: A systematic review. Ann Med 2012; 44: 305-12.
    • (2012) Ann Med , vol.44 , pp. 305-312
    • Peters, S.A.1    Den Ruijter, H.M.2    Bots, M.L.3
  • 86
    • 78751620578 scopus 로고    scopus 로고
    • Microvascular function predicts cardiovascular events in primary prevention: Long-term results from the Firefighters and Their Endothelium (FATE) study
    • Anderson TJ, Charbonneau F, Title LM, et al., Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 2011; 123: 163-9.
    • (2011) Circulation , vol.123 , pp. 163-169
    • Anderson, T.J.1    Charbonneau, F.2    Title, L.M.3
  • 87
    • 69449105430 scopus 로고    scopus 로고
    • Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis
    • Yeboah J, Folsom AR, Burke GL, et al., Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-9.
    • (2009) Circulation , vol.120 , pp. 502-509
    • Yeboah, J.1    Folsom, A.R.2    Burke, G.L.3
  • 88
    • 31944438817 scopus 로고    scopus 로고
    • Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: A community-based study
    • DOI 10.1161/01.HYP.0000199605.35173.14
    • Kullo IJ, Bielak LF, Turner ST, Sheedy PF, Peyser PA,. Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: a community-based study. Hypertension 2006; 47: 174-9. (Pubitemid 43189760)
    • (2006) Hypertension , vol.47 , Issue.2 , pp. 174-179
    • Kullo, I.J.1    Bielak, L.F.2    Turner, S.T.3    Sheedy II, P.F.4    Peyser, P.A.5
  • 89
    • 84858306926 scopus 로고    scopus 로고
    • Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study
    • Kavousi M, Elias-Smale S, Rutten JH, et al., Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med 2012; 156: 438-44.
    • (2012) Ann Intern Med , vol.156 , pp. 438-444
    • Kavousi, M.1    Elias-Smale, S.2    Rutten, J.H.3
  • 90
    • 77249099782 scopus 로고    scopus 로고
    • Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults
    • Rodondi N, Marques-Vidal P, Butler J, et al., Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am J Epidemiol 2010; 171: 540-9.
    • (2010) Am J Epidemiol , vol.171 , pp. 540-549
    • Rodondi, N.1    Marques-Vidal, P.2    Butler, J.3
  • 91
    • 84856106620 scopus 로고    scopus 로고
    • Systematic review of guidelines on peripheral artery disease screening
    • Ferket BS, Spronk S, Colkesen EB, Hunink MG,. Systematic review of guidelines on peripheral artery disease screening. Am J Med 2012; 125: 198-208.
    • (2012) Am J Med , vol.125 , pp. 198-208
    • Ferket, B.S.1    Spronk, S.2    Colkesen, E.B.3    Hunink, M.G.4
  • 93
    • 33751233828 scopus 로고    scopus 로고
    • Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies
    • DOI 10.1185/030079906X148472
    • Bots ML,. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006; 22: 2181-90. (Pubitemid 44789983)
    • (2006) Current Medical Research and Opinion , vol.22 , Issue.11 , pp. 2181-2190
    • Bots, M.L.1
  • 94
    • 77954812247 scopus 로고    scopus 로고
    • Imaging of atherosclerosis: Carotid intima-media thickness
    • O'Leary DH, Bots ML,. Imaging of atherosclerosis: carotid intima-media thickness. Eur Heart J 2010; 31: 1682-9.
    • (2010) Eur Heart J , vol.31 , pp. 1682-1689
    • O'Leary, D.H.1    Bots, M.L.2
  • 95
    • 38849140265 scopus 로고    scopus 로고
    • Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine
    • DOI 10.1016/j.echo.2007.11.011, PII S0894731707008188
    • Stein JH, Korcarz CE, Hurst RT, et al., Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93-111. (Pubitemid 351193107)
    • (2008) Journal of the American Society of Echocardiography , vol.21 , Issue.2 , pp. 93-111
    • Stein, J.H.1    Korcarz, C.E.2    Hurst, R.T.3    Lonn, E.4    Kendall, C.B.5    Mohler, E.R.6    Najjar, S.S.7    Rembold, C.M.8    Post, W.S.9
  • 96
    • 84857628939 scopus 로고    scopus 로고
    • Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: A direct comparison
    • Peters SA, den Ruijter HM, Palmer MK, et al., Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison. J Intern Med 2012; 271: 247-56.
    • (2012) J Intern Med , vol.271 , pp. 247-256
    • Peters, S.A.1    Den Ruijter, H.M.2    Palmer, M.K.3
  • 97
    • 77955129054 scopus 로고    scopus 로고
    • Ultrasound protocols to measure carotid intima-media thickness in trials; Comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia
    • Dogan S, Duivenvoorden R, Grobbee DE, et al., Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann Med 2010; 42: 447-64.
    • (2010) Ann Med , vol.42 , pp. 447-464
    • Dogan, S.1    Duivenvoorden, R.2    Grobbee, D.E.3
  • 98
    • 77950327422 scopus 로고    scopus 로고
    • Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk in Communities) study
    • Nambi V, Chambless L, Folsom AR, et al., Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010; 55: 1600-7.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1600-1607
    • Nambi, V.1    Chambless, L.2    Folsom, A.R.3
  • 99
    • 20444373191 scopus 로고    scopus 로고
    • Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis heart study
    • DOI 10.1016/j.jacc.2005.02.088, PII S0735109705010314
    • Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD,. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46: 158-65. (Pubitemid 40905145)
    • (2005) Journal of the American College of Cardiology , vol.46 , Issue.1 , pp. 158-165
    • Arad, Y.1    Goodman, K.J.2    Roth, M.3    Newstein, D.4    Guerci, A.D.5
  • 100
    • 77951639385 scopus 로고    scopus 로고
    • Coronary artery calcium score and risk classification for coronary heart disease prediction
    • Polonsky TS, McClelland RL, Jorgensen NW, et al., Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303: 1610-6.
    • (2010) JAMA , vol.303 , pp. 1610-1616
    • Polonsky, T.S.1    McClelland, R.L.2    Jorgensen, N.W.3
  • 101
    • 70349210201 scopus 로고    scopus 로고
    • Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)
    • Budoff MJ, McClelland RL, Nasir K, et al., Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2009; 158: 554-61.
    • (2009) Am Heart J , vol.158 , pp. 554-561
    • Budoff, M.J.1    McClelland, R.L.2    Nasir, K.3
  • 103
    • 80051964418 scopus 로고    scopus 로고
    • Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: Implications for the JUPITER population from MESA, a population-based cohort study
    • Blaha MJ, Budoff MJ, DeFilippis AP, et al., Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 2011; 378: 684-92.
    • (2011) Lancet , vol.378 , pp. 684-692
    • Blaha, M.J.1    Budoff, M.J.2    Defilippis, A.P.3
  • 105
    • 33747135440 scopus 로고    scopus 로고
    • From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report
    • Naghavi M, Falk E, Hecht HS, et al., From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006; 98: 2H-15H.
    • (2006) Am J Cardiol , vol.98
    • Naghavi, M.1    Falk, E.2    Hecht, H.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.